6.59
+0.30
+(4.77%)
As of 2:18:58 PM EST. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 2 |
| Avg. Estimate | -0.24 | -0.27 | -0.98 | -1 |
| Low Estimate | -0.25 | -0.3 | -0.99 | -1.06 |
| High Estimate | -0.23 | -0.24 | -0.96 | -0.94 |
| Year Ago EPS | -0.25 | -0.25 | -1.16 | -0.98 |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 2 |
| Avg. Estimate | -- | 200k | 100k | 4.8M |
| Low Estimate | -- | 100k | 100k | 4M |
| High Estimate | -- | 300k | 100k | 5.6M |
| Year Ago Sales | 41k | -- | 306k | 100k |
| Sales Growth (year/est) | -100.00% | 0.00% | -67.32% | 4,700.00% |
Earnings History
| Currency in USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|---|
| EPS Est. | -0.26 | -0.27 | -0.26 | -0.22 |
| EPS Actual | -0.25 | -0.25 | -0.25 | -0.24 |
| Difference | 0.01 | 0.02 | 0.02 | -0.02 |
| Surprise % | 3.85% | 7.41% | 5.66% | -9.09% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.24 | -0.27 | -0.98 | -1 |
| 7 Days Ago | -0.24 | -0.24 | -0.98 | -1 |
| 30 Days Ago | -0.24 | -0.24 | -0.98 | -1 |
| 60 Days Ago | -0.24 | -0.24 | -0.98 | -1 |
| 90 Days Ago | -0.24 | -0.24 | -0.97 | -0.97 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | -- | -- | -- |
| Up Last 30 Days | 1 | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | 1 |
| Down Last 30 Days | -- | -- | -- | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| SERA | 4.00% | -8.00% | 15.95% | -2.56% |
| S&P 500 | 9.01% | 10.57% | 14.00% | 13.70% |
Upgrades & Downgrades
| Maintains | Citigroup: Neutral to Neutral | 8/10/2023 |
| Maintains | Citigroup: Neutral | 11/10/2022 |
| Maintains | Oppenheimer: Outperform | 8/29/2022 |
| Initiated | Berenberg: Buy | 4/27/2022 |
| Downgrade | Citigroup: Buy to Neutral | 3/30/2022 |
| Initiated | Oppenheimer: Outperform | 11/19/2021 |
Related Tickers
VSD-B.ST VibroSense Dynamics AB ser. B
0.6980
-10.05%
TLSIW TriSalus Life Sciences, Inc.
1.2881
+17.10%
BIOVIT.ST Bio Vitos Pharma AB (publ)
0.1370
+1.48%
SPEC.ST SpectraCure AB (publ)
2.0150
-7.57%
UTRS Minerva Surgical, Inc.
0.0001
0.00%
LUNG Pulmonx Corporation
5.74
-1.54%
QLIFE.ST Qlife Holding AB (publ)
2.1400
-2.73%
SGHT Sight Sciences, Inc.
3.0550
+0.16%
LIVN LivaNova PLC
50.84
+0.22%
QLINEA.ST Q-linea AB (publ)
0.3115
-2.81%